Welcome to Elite Trade Club’s weekly stock watchlist, an exclusive newsletter for our most active readers.
A construction-centric retail stock faces declining homebuilder sentiment pre-earnings, an entertainment stock may be due for a short squeeze as its summer season heats up, and traders may want to reconsider a much-maligned healthcare stock’s near-term prospects.
Here’s what to watch this week.
High-probability trades start with proven patterns—and these 5 laminated cheatsheets make them easy to find and follow.
Each pattern has a backtested track record of up to 90% win rates.
These tools are built to help traders remove emotion, time their entries, and approach the market with more precision.
Available now for free—limited quantity remaining.
[Click Here to Grab All 5 Cheatsheets]
*The profits and performance shown are not typical and you may lose money. We make no future earnings claims. All trades expressed are from historical, backtested data in order to demonstrate the potential of the system.
The Home Depot
Ticker: HD | Market Cap: $378.47B | Catalyst: Earnings on Tuesday
Homebuilder sentiment cratered last week, continuing its 2025 downward trend and flying in the face of the typical cyclical trend of spring bringing renewed activity across housing markets. All that to say, of course, that much like tariffs weighed heavily on Walmart’s (NYSE: WMT) earnings last week, poor homebuilder and construction prospects could limit Home Depot’s optimistic forward guidance prospects.
Pre-tariff forward guidance for 2025 included 3% revenue expansion, 13 new store additions, and a modest EPS decline. If homebuilder sentiment is a leading indicator for Home Depot’s adjusted guidance, expect bad news on Tuesday. Analysts forecast a $3.59 quarterly EPS and 8% year-over-year revenue improvement.
AI’s capabilities are growing rapidly—handling layered conversations, correcting itself, and adapting in real time.
This shift is opening up new frontiers for early investors.
A free report just revealed 5 high-potential stocks—including one under-the-radar name with breakout potential.
These tickers are positioned to ride the AI boom in its most advanced form yet.
[See the Top 5 AI Stocks – Free Access]
(By submitting your email address, you will receive a free subscription to the Profit From The Pros e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time.)
Lucky Strike Entertainment
Ticker: LUCK | Market Cap: $1.29B | Catalyst: High Short Interest; Cyclical Improvement
At a whopping 44% short interest, there’s been a concerted effort to keep this destination entertainment stock suppressed. And it’s worked, somewhat - shares are down 10% on the year and nearly 25% since May 2024.
But LUCK’s summer busy season is shaping up to be strong, positioning the heavily-shorted stock for a possible squeeze.
The company’s annual Summer Season Pass initiative, a major driver of seasonal sales and foot traffic, sold over 200% more individual passes than in 2024. The company also has three new water parks in its portfolio and seven additional family entertainment centers, all of which combine to create conditions for a strong season - and possible short squeeze when all’s said and done.
UnitedHealth Group
Ticker: UNH | Market Cap: $264.80B | Catalyst: Oversold Indicators
By now, you’re doubtlessly familiar with UNH’s myriad problems over the past year that reads like a novel - an assassination, Medicare fraud, execs suddenly stepping down due to “personal reasons.” We aren’t here to litigate their many issues, nor determine whether the company is “too big to fail” as some claim, mostly citing Crowdstrike’s (NASDAQ: CRWD) return to grace following their own major issues last summer.
Instead, let’s look at a basic technical indicator showing UNH stock is grossly oversold and, in all likelihood, due for a (temporary, at least) bounce. UNH’s RSI sits at a rock-bottom 17.76. Likewise, a CNBC report this week showed significant insider buying at the firm, meaning the bottom may be in (for now).
Amphenol
Ticker: APH | Market Cap: $105.09B | Catalyst: All-Time High
Never heard of Amphenol? Don’t worry, neither have we - but this fiber optics stock has slowly accumulated massive momentum over the past few weeks to rocket to an all-time high. Returning nearly 62,000% since its 1991 market debut, Amphenol tripled over the past few years as a “pick and shovel” stock providing much-needed infrastructure for AI’s expansion and data center growth.
Shareholders recently approved an expanded share count authorization to 5 billion from 2 billion, giving Amphenol some financing flexibility in the coming years. If execs issue new equity, remember that existing shareholders will be diluted - but, with APH’s current momentum, that should prove a temporary blip if it drops per-share pricing in the first place.
Hinge Health
Ticker: HNGE | Catalyst: IPO on Thursday
Hinge Health, a physical therapy-centric telehealth stock, is the latest to grab a piece of the rapidly improving IPO market as it targets a $3B valuation for Thursday’s initial listing.
The company helps patients treat musculoskeletal damage, heal post-surgery, and manage chronic pain -all via software and in the comfort of the patient’s home. Hinge reported record Q1 profits as one of the few remote-first medical provider platforms offering physical therapy, and plans to list between $28 and $32 per share.
From construction stocks facing housing market pressure to an entertainment stock’s significant short interest, oversold indicators, fiber optics momentum, and a telehealth company’s IPO debut, this week’s catalysts could spark significant market swings.
Gear up for action and position wisely to capitalize on the volatility ahead.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.